Brokerages Anticipate Scpharmaceuticals Inc (SCPH) to Post ($0.58) EPS

Share on StockTwits

Scpharmaceuticals Inc (NASDAQ:SCPH) has earned a consensus broker rating score of 1.00 (Strong Buy) from the three brokers that cover the company, Zacks Investment Research reports. Three analysts have rated the stock with a strong buy recommendation.

Brokerages have set a 1-year consensus target price of $12.67 for the company and are forecasting that the company will post ($0.58) earnings per share for the current quarter, according to Zacks. Zacks has also given Scpharmaceuticals an industry rank of 101 out of 255 based on the ratings given to its competitors.

SCPH has been the subject of a number of research reports. ValuEngine raised Scpharmaceuticals from a “sell” rating to a “hold” rating in a research report on Wednesday, May 2nd. Zacks Investment Research downgraded Scpharmaceuticals from a “hold” rating to a “sell” rating in a research report on Friday, May 11th. Jefferies Financial Group lowered their price target on Scpharmaceuticals from $26.00 to $12.00 and set a “buy” rating for the company in a research report on Thursday, June 14th. BMO Capital Markets lowered their price target on Scpharmaceuticals from $24.00 to $14.00 and set an “outperform” rating for the company in a research report on Thursday, June 14th. Finally, Leerink Swann lowered their price target on Scpharmaceuticals from $20.00 to $12.00 and set an “outperform” rating for the company in a research report on Thursday, June 14th.

Hedge funds and other institutional investors have recently modified their holdings of the company. California State Teachers Retirement System purchased a new stake in shares of Scpharmaceuticals in the first quarter worth about $139,000. Schwab Charles Investment Management Inc. purchased a new stake in shares of Scpharmaceuticals in the first quarter worth about $167,000. Acadian Asset Management LLC purchased a new stake in shares of Scpharmaceuticals in the second quarter worth about $169,000. Bank of New York Mellon Corp purchased a new stake in shares of Scpharmaceuticals in the fourth quarter worth about $414,000. Finally, Millennium Management LLC purchased a new stake in shares of Scpharmaceuticals in the fourth quarter worth about $462,000. 44.74% of the stock is owned by institutional investors.

SCPH stock traded up $0.01 during trading on Friday, reaching $4.59. 52,710 shares of the stock traded hands, compared to its average volume of 48,005. Scpharmaceuticals has a 52-week low of $4.32 and a 52-week high of $18.17. The company has a current ratio of 19.23, a quick ratio of 19.23 and a debt-to-equity ratio of 0.10. The company has a market cap of $84.92 million and a PE ratio of -0.57.

About Scpharmaceuticals

scPharmaceuticals Inc, a clinical-stage pharmaceutical company, engages in the development and commercialization of various pharmaceutical products. The company's lead product candidate is Furoscix, a drug-device combination product that is under development for treatment of worsening or decompensated heart failure outside of the inpatient setting.

Featured Story: Average Daily Trade Volume – What It Means In Stock Trading

Get a free copy of the Zacks research report on Scpharmaceuticals (SCPH)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Receive News & Ratings for Scpharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Scpharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.

 


Latest News

Yu Darvish Receives Cortisone Shot for Elbow Impingement
Yu Darvish Receives Cortisone Shot for Elbow Impingement
Red Sox and Brandon Phillips Agree to Minor League Deal
Red Sox and Brandon Phillips Agree to Minor League Deal
Chris Sale Proves He is 2018 AL Cy Young Candidate
Chris Sale Proves He is 2018 AL Cy Young Candidate
Strong Results by Clint Frazier Could Keep Him with Yankees
Strong Results by Clint Frazier Could Keep Him with Yankees
Giants Closer Breaks Hand Punching Door Following Poor Outing
Giants Closer Breaks Hand Punching Door Following Poor Outing
Evan Longoria Out Six to Eight Weeks With Broken Hand
Evan Longoria Out Six to Eight Weeks With Broken Hand


Leave a Reply

 
© 2006-2018 BBNS.